Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the Tetravalent Dengue Vaccine, CYD-TDV (Dengvaxia®) in the Philippines

NCT03803618 is registered in ClinicalTrials.gov with University of the Philippines as lead sponsor.

NCT NCT03803618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03803618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the Tetravalent Dengue Vaccine, CYD-TDV (Dengvaxia®) in the Philippines
Lead sponsor
University of the Philippines
Phase
Observational
Overall status
Completed
Start date
September 1, 2017
Completion date
April 30, 2023
Enrollment
2,081 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dengue, severe dengue, virologically confirmed dengue